Zobrazeno 1 - 6
of 6
pro vyhledávání: '"I F, Trocóniz"'
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
This commentary provides an overview of recent examples of pharmacometrics applied during the clinical development of two antagonists of the programmed death-1 (PD-1) cell surface receptor, pembrolizumab and nivolumab. Despite the remarkable achievem
Autor:
I F, Trocóniz
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 24
Autor:
M J, Garrido, I F, Trocóniz
Publikováno v:
Journal of pharmacological and toxicological methods. 42(2)
During the past decades the use of methadone has been increased as a result of the interest of optimizing its therapeutics in opioid addicts, one of the groups with higher risk for AIDS infection. However standard dose of methadone are far from being
Autor:
C, Aguirre, I F, Trocóniz, A, Valdivieso, R M, Jiménez, J P, González, R, Calvo, J M, Rodríguez-Sasiaín
Publikováno v:
Research communications in molecular pathology and pharmacology. 92(1)
The pharmacokinetic and pharmacodynamic profiles of penbutolol were examined in healthy volunteers and in cancer patients using a pharmacokinetic/pharmacodynamic (pk/pd) model. After receiving a 40 mg single oral dose of penbutolol, the absorption ra
Autor:
I F, Trocóniz
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 18
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.